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Aim: In this study, we aimed to examine the efﬁcacy of thymoquinone (TQ) treatment in
acetaminophen-induced liver toxicity in rats.
Methods: Forty Wistar Albino rats were used for the study (four groups, with 10 rats for each group).
Animals in the control group were not given any medication. In the thymoquinone (TQ) group, animals
were given three times 5 mg/kg oral thymoquinone for every six hours, which equals to a total dose of
15 mg/kg. In the acetaminophen (APAP) group, animals were given APAP at a single dose of 500 mg/kg
orally. In the APAP þ TQ group, animals were given 500 mg/kg APAP orally followed by three doses of TQ
at a 15 mg/kg total dose in an 18-h time interval. All animals were sacriﬁced at the 24th hour. Alanine
amino transferase (ALT), aspartat amino transferase (AST), superoxide dismutase (SOD), oxidized
glutathione (GSSG), glutathione peroxides (GSH-Px), and malondialdehyde (MDA) activities were
measured in rat blood. Histopathological examination was also performed.
Results: Serum ALT, AST levels, GSSG, and SOD activity as well as the serum and tissue MDA levels were
found to be higher in the APAP group than in the control group (p  0.001). Likewise, serum GSH-Px
activity was found to be lower in the APAP group (p  0.001). In contrast, in the APAP þ TQ group,
serum ALT, AST levels, GSSG, SOD activity and the serum and tissue MDA levels were found to be lower
compared to that of the APAP group. This difference was statistically signiﬁcant (p  0.001). In the
APAP þ TQ group, the GSH-Px activity was found to be signiﬁcantly higher compared to the APAP group
(p < 0.05). In contrast to this ﬁnding, the GSH-Px activity in the APAP þ TQ group was found to be lower
than that of the control group (p  0.001). Histopathological analysis revealed signiﬁcant liver necrosis
and toxicity with a high dose of APAP where TQ treatment was related with signiﬁcantly lower liver
injury scores.
Conclusion: TQ treatment may have an important therapeuthic effect via the upregulation of antioxidant
systems in the APAP-induced liver hepatotoxicity in rats.
 2013 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Acetaminophen (APAP) is one of the most commonly used
analgesic and antipyretic drugs. It is considered as a safe choice
when administered at therapeutic doses. In overdoses, acetamin-
ophen can induce hepatic necrosis and death.1 Oxidative stress is a
factor that leads to tissue damage. It is one of the most important
factors that exacerbate damage by APAP. Following the oral
administration of APAP, acetaminophen is metabolically activatedx: þ90 412 2488523.
.
ciates Ltd. Published by Elsevier Ltby cytochrome P450 to form a toxic reactive metabolite N-acetyl-p-
benzoquinoneimine (NAPQI).2 NAPQI is detoxiﬁed by glutathione
(GSH) to form an acetaminophen-GSH conjugate. After a toxic dose
of acetaminophen, total hepatic GSH is depleted by as much as 90%.
As a result, centrilobular necrosis and cell death occur.2e4When the
development of NAPQI and the depletion of hepatic glutathione
store to a critical level, hepatotoxicity occurs. Majority of patients
exposed to toxicity develop elevation in the levels of alanine amino
transferase (ALT) and aspartat amino transferase (AST) within
24 h of ingestion.5
Antioxidant agents have therapeutic potential in drug-induced
toxicity.6 N-acetyl cystein (NAC) is being used as a standardd. All rights reserved.
Table 1
The distribution of liver enzymes between the groups.
Group I
(control)
Group II
(TQ)
Group III
(APAP)
Group IV
(APAP þ TQ)
ALT (U/L) 43.3  10.7 59.1  15.4 131  32.8a 52.9  10.3b
AST (U/L) 155.6  30.3 155.7  50.4 309.4  109.5a 185.6  58.3b
Data were given as mean  SD.
TQ: Thymoquinone, APAP: Acetaminophene, ALT: alanine aminotransferase, AST:
aspartat aminotransferase.
a Signiﬁcantly different when compared with control group, (p  0.001).
b Signiﬁcantly different when compared with APAP group, (p  0.001).
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well studied and allergic reactions may have occurred with NAC. In
cases of drug allergy, no established alternative agent has been
discovered until now.
Thymoquinone (TQ) is the most potent component of Nigella
sativa.7 Protective effects of orally administered TQ were estab-
lished in doxorubicin,5 carbon tetrachloride,8 cisplatin,9 ethanol10
and aﬂotoxin11 induced oxidative damage. In addition, anti-in-
ﬂammatory,12 anti-tumoral,13 anti-microbial,14 anti-histaminic10
and immuno-modulatory15 effects of TQ have been reported.
Moreover, it has been suggested that TQ may act as an antioxidant
agent and prevent the membrane lipid peroxidation in
hepatocytes.16
In this study, we aimed to examine the efﬁcacy of TQ treatment
in APAP-induced hepatotoxicity in rats.
2. Materials and methods
Our study included 40 Wistar-Albino rats, each weighing 200e
250 g. The rats were obtained from the Dicle University Health
Sciences Application and Research Center. The study protocol was
approved (2011e38) by the Committee of Experimental Animals of
Dicle University. All experimental procedures complied with the
committee’s Guide for the Care and Use of Laboratory Animals. Rats
were housed under standard conditions in an airconditioned room
with 12 h light and dark cycles and with constant temperature
(22  2 C). The rats were housed in cages and allowed free access
to standard rat chow and water before the experiments. The ani-
mals were fasted overnight the day before the study, but had access
to water ad libitum.
2.1. Study design
Acetaminophen (APAP) was purchased from Merck (Germany).
It was dissolved in warm saline (65 C) and cooled to room tem-
perature before oral administration. Thymoquinone (TQ) was pur-
chased from SigmaeAldrich (Catalog no.: 274666). It was dissolved
in warm drinking water (65 C) and cooled to room temperature
before oral administration.
Forty Wistar-Albino rats were divided into four groups
(n ¼ 10). Group I (Control): no drug was given. Group II (TQ): TQ
was given at a triple dose (0, 6, 12) of 5 mg/kg via the oral
route.17e20 Group III (Acetaminophen, APAP): APAP was given at a
single dose of 500 mg/kg via the oral route. Group IV
(APAP þ TQ): APAP was given at a single dose of 500 mg/kg via
the oral route and TQ was given at a triple dose1,6,12 of 5 mg/kg
via the oral route.
After a period of 24 h, the rats were anesthetized with 50 mg/kg
ketamine hydrochloride (Ketalar; Parke Davis, Eczacibasi, Istanbul,
Turkey) and 10 mg/kg xylazine (Rompun; Bayer AG, Leverkusen,
Germany) via intramuscular injection and sacriﬁced by taking
blood from the heart for biochemical analysis. Likewise, liver tis-
sues were removed for histopathological examinations.
Alanine amino transferase (ALT), aspartat amino transferase
(AST), superoxide dismutase (SOD), oxidized glutathione (GSSG),
glutathione peroxides (GSH-Px), and malondialdehyde (MDA) ac-
tivities were measured in rat blood. Histopathological examination
was also undertaken.
2.2. Biochemical analysis
Each collected blood sample was immediately centrifuged at
4000 rpm for 10 min and then transferred into an eppendorf tube.
Samples were transferred on ice and kept in 80 C deep freeze
until the completion of the study.Malonyldialdehyde (MDA) content was measured spectropho-
tometrically as described previously.17 GSH-Px (U/L) and
Glutatyonin-GSSG (mmol/L) levels were determined with colori-
metric assay kit (Cayman Ch. Co. AnnArbo. MI, USA). SOD activity
was measured according to the method described by Fridovich.18
Plasma aspartat transaminase (AST) and alanine transaminase
(ALT) levels were measured by photometric method with an
automated analyzer (Architect c16000; Abbott Laboratories, Abbott
Park, IL, USA).
2.3. Histopathological evaluation
The liver tissues were taken for histopathological evaluation.
Foreign tissue residues and blood were removed, washed with
saline, and put into plastic containers holding 10% formaldehyde
solution.
Tissue specimens were ﬁxed in 10% formalin for 48 h, then
embedded in parafﬁn and cut into 5 mm sections. Slides were
stained with hematoxylin-eosin. The sections were examined un-
der a light microscope (Nikon ECLIPSE 80i) using 200magniﬁcation
to assess the degree of liver injury by a liver pathologist blinded to
the grouping of the animals.
Hepatic injury was graded as follows: grade 0: minimal or no
evidence of injury; grade 1: mild injury characterized by cyto-
plasmic vacuolization and focal nuclear pyknosis; grade 2:
moderate injury exhibiting cytoplasmic vacuolization, conﬂuent
areas of hepatocyte ballooning but no frank necrosis, sinusoidal
dilatation and congestion, and blurring of intercellular borders;
grade 3: moderate to severe injury with areas of coagulative
necrosis, cytoplasmic hypereosinophilia, extensive sinusoidal
dilatation and congestion; grade 4: severe injury consisting of
severe conﬂuent coagulative necrosis and disintegration of and
hemorrhage into hepatic chords leading to loss of tissue
architecture.19,20
2.4. Statistical analysis
Statistical analysis was performed using SPSS 11.5 for Windows
(SPSS Inc., Chicago, IL, USA). Data were presented as
mean  standard deviation (SD) values. Groups were compared
using the nonparametric KruskaleWallis test. The ManneWhitney
U test was used for binary comparisons. A p value of less than 0.05
was considered signiﬁcant.
3. Results
The liver enzyme levels of all groups were shown in Table 1. ALT
and AST levels were found higher in the APAP group compared to
that of the control group (p < 0.001). The mean ALT and AST levels
of rats treated with APAPþ TQwere found to be lower compared to
those treated with APAP only (p < 0.001). Both means of the two
enzyme levels of the TQ group were similar to that of the control
group (p > 0.05) (Fig. 1).
Table 2
Inter-group comparison of biochemical markers in serum and liver tissue.
Group I
(control)
Group II
(TQ)
Group III
(APAP)
Group IV
(APAP þ TQ)
GSSG (mmol/L) 264  45.2 179  49.8a 429.3  128.3a,b 192.5  56.8c
GSH-Px (U/L) 56.5  12.2 57.4  14.9 21.5  5.2a,b 37.1  8b,d,e
SOD (U/L) 5.5  0.5 5.8  0.4 7.9  1.1a,b 5.7  0.4c
MDA (nmol/L) 133.1  29.8 119.7  26.6 253.4  56.6a,b 162.5  39.3c
Liver-MDA
(nmol/g prt)
0.37  0.08 0.33  0.07 0.71  0.15a,b 0.45  0.11c
Data were given as mean  SD.
GSSG: Okside glutatyon, GSH-Px: glutatyon peroksidaz, SOD: süperoksit dismutaz,
MDA: malondialdehyde, TQ: Thymoquinone, APAP: Acetaminophene.
a Signiﬁcantly different when compared with control group, (p  0.001).
b Signiﬁcantly different when compared with TQ group, (p  0.001).
c Signiﬁcantly different when compared with APAP group, (p  0.001).
d Signiﬁcantly different when compared with control group, (p < 0.01).
e Signiﬁcantly different when compared with APAP group, (p < 0.05).
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and liver tissue of the APAP group were signiﬁcantly elevated
compared to that of the control group (p  0.001) (Shown in
Table 2) (Figs. 2e5 respectively). In contrast to the APAP only group,
the serum GSSG, SOD activities, and MDA levels in both the serum
and liver tissue of the APAPþ TQ groupwere found to be signiﬁcant
(p  0.001). When the serum SOD activities, and serum and tissue
MDA levels of the control, TQ, and APAP þ TQ groups were
compared, no signiﬁcant difference was found between groups
(p > 0.05). In addition to these ﬁndings, the serum GSSG activity in
the TQ group was found to be lower than that of the control group
(p  0.001). In terms of mean serum GSH-Px activity, the APAP
group had signiﬁcantly lower levels compared to the control group
(p  0.001). Although the mean GSH-Px activity in the APAP þ TQ
group was found to be higher than that of the APAP only group, the
activity level was found to be signiﬁcantly lower than that of the
control group (p < 0.05 vs p  0.001). The difference in the GSH-Px
activities of the control and TQ groups were found to be similar
(p > 0.05) (Fig. 6).
Histopathological changes in the TQ group were found to be
similar with the histopathological changes in the control group
(p > 0.05). In contrast to the TQ group, signiﬁcant tissue damage
was established in the APAP group compared with the control
group (p  0.001). Signiﬁcant lower scores were determined in the
APAPþ TQ groupwhen compared with the APAP group (p 0.001),
while higher scores were obtained when compared with the con-
trol group (p  0.001) (Fig. 7). Histopathological examination re-
sults are shown in Table 3.
4. Discussion
Acetaminophen (N-acetyl-p-aminophenol [APAP]) is a widely
used medication that can cause fatal hepatotoxicity hepatic ne-
crosis, renal toxicity and, rarely, death when administered at toxic
doses. Children are particularly at risk for accidental overdose.
APAP is also often used as a suicidal agent in the elderly.
The majority of the therapeutic doses (80e85%) of APAP is
glucuronidated or sulfated and then excreted. A small percentage
(10e15%) is metabolized by cytochrome P45 0 enzymes (CYP) to the
reactive intermediate N-acetyl-p-benzoquinone imine (NAPQI),
which is readily detoxiﬁed by conjugation with glutathione (GSH).
In cases of APAP overdose, induction of CYP enzymes, decrease in
glutathione stores, and inhibition of glucronidation result in
elevated levels of toxic APAP metabolite.2,21 Inadequate detoxiﬁ-
cation of NAPQI leads to intracellular structural damage followed by
centrilobular necrosis. The early phase of toxication resembles thatFig. 1. The distribution of liver enzymes between the groups.of mitochondrial disfunction, while the late phase includes mito-
chondrial collapse, oncotic necrosis and, subsequently, in vivo cell
death.2,4
It is well known that oxidative stress plays an important role in
APAP toxicity. Increased NAPQI levels in APAP overdose results in
the increased formation of O2∙- hydrogen peroxide (H2O2). The
high oxidative capacity of NAPQI leads to thiol oxidation, which is
thought to be themajor factor behind liver toxicity. Increased levels
of NAPQI are associated with increased GSH/GSSG ratio and
decreased NADPH/NADP þ ratio. Decreased GSH concentrations
result in reduced activity of GPx enzyme function.22
N-acetylcysteine (NAC) is the standard clinical antidote of choice
in treating acetaminophen-induced hepatotoxicity. The role of N-
acetylcysteine in the treatment of acetaminophen toxicity is to
replace stores of intracellular hepatic glutathione, a free radical
scavenger, binding NAPQI directly and increasing microcirculatory
oxygenation.23 However, it has several adverse effects, including
nausea and vomiting, which are the most common adverse effects
of NAC.24 Although NAC is a safe and effective antidote for APAP
toxicity, in terms of adverse effect experiences, an alternative agent
may be useful. Thus, alternative agents that are capable of reducing
oxidative stressdthemainmechanism in APAP toxicitydhave to be
developed.
Nagi et al. reported protective effects on the prophilactic use of
orally administered TQ in APAP-induced hepatotoxicity via anti-
oxidant mechanisms.6 Our study is the ﬁrst study in literature thatFig. 2. Serum Glutathion (GSSG) levels.
Fig. 3. Serum Superoxide dismutase (SOD) levels.
Fig. 5. Liver Tissue Malondialdehyde (Liver-MDA) levels.
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exposure. In our study, we have shown a remarkable reduction in
APAP-induced ALT, AST levels, oxidative stress, and tissue damage.
Thymoquinone (TQ; 2-isopropyl-5-methyl-1,4-benzoquinone)
is the bioactive component of N. sativa seeds and it has various
pharmacological effects.25 It is reported that thymoquinone possess
strong antioxidant properties and protect several organs against
oxidative damage induced by free radical-generating agents.6,26,27
In this study, APAP administration induced signiﬁcantly high
MDA levels compared to the control group. Several studies showed
40e120% elevated MDA levels compared to the control.6
GSH is the major intracellular defense molecule against ROS and
electrophilic xenobiotics. Excessive exposure to xenobiotics re-
duces hepatic GSH concentrations.27 GSH is essential in protecting
thiol and other nucleophilic groups from the toxic metabolite of
APAP. Therefore, it is concluded that the key factor in determining
the extension of APAP-induced liver damage is intracellular GSH
levels.
In our study, we found that APAP administration resulted in
remarkably reduced GSH levels. Several studies investigated
different doses and durations of APAP toxicity and reported similar
ﬁndings with our study.21 Meotti et al. reported a signiﬁcant
reduction in GSH levels four hours following APAP administration,
while no signiﬁcant change in GSH levels 24 h after toxic dose.28
Authors suggested that the adaptive response of hepatocytes
might be responsible for the initial measurements, while ROS
detoxiﬁcation could be the reason for late results. We have
administered a higher APAP dose in this study and GSH levels wereFig. 4. Serum Malondialdehyde (MDA) levels.found to be signiﬁcantly lower in the control at the end of the 24th
hour. This ﬁnding correlated with the ﬁndings of previous studies.
Antioxidant enzymes like SOD and GSH-Px are important for the
elimination of ROS. It has been suggested that the tissue levels of
SOD and GSH-Px may reﬂect ROS levels.27 In addition, MDA levels
can be a reliable indicator of lipid peroxidation and oxidative
stress.29 Thus, ROS can be evaluated indirectly with the determi-
nation of MDA and the levels of some antioxidant enzyme activities
like SOD or GSH-Px in tissue.30
Vaquero et al. showed the antioxidant effects of TQ via the
reduction of diphenylpcriylhydracyl (DPPH), an oxidative radical,
by TQ.31 Another study showed the protective effects of TQ in
doxorubicin-induced cardio toxicity that resulted from ROS for-
mation and oxidative stress.5 APAP-induced hepatotoxicity resulted
in elevated superoxide and hydrogen peroxide levels and decreased
GSH/GSSG ratio.3,32 As a consequence of impairment in antioxidant
defense systems, ROS and lipid peroxidation increases. In our study,
the APAP group demonstrated an increase in MDA and GSSG levels
in addition to decreased GSH-Px activity.
ROS attacks membrane lipids and results to lipid peroxidation.
MDA is the end-product of lipid peroxidation. It serves as an index
of lipid peroxidation. In our study, the increase of MDA in liver
tissue and in serum has improved in the rats’ exposure to APAP as a
result of TQ treatment (p 0.001). This decrease in the level of MDA
suggests that TQ may be effective in the prevention of lipidFig. 6. Serum Glutathion peroxidase (GSH-PX) levels.
Fig. 7. Rat liver tissues histopathological changes.
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which was measured in terms of MDA, a stable metabolite of the
free radical-mediated lipid peroxidation cascade.
Similar studies have shown the protective effect of TQ in carbon
tetrachloride-induced hepatotoxicity via the protection of lipid
peroxidation.8 Another interesting ﬁnding in our study is the
correlated MDA levels in both APAP þ TQ and control groups.
Similar MDA levels in these groups indicate the protective effect of
TQ in oxidative stress.
Superoxide dismutase (SOD) is the major anti-oxidant enzyme-
reducing superoxide.33 We found that similar SOD levels in the
control and TQ groups indicates that TQ has positive effects on
oxidative stress. In our study, SOD levels in the APAP group
increased in association with increased free radicals. An interesting
ﬁnding in our study is the decreased SOD levels in the APAP þ TQ
treated group, which is similar with the control group. In contrast
to our study, previous studies showed a decreased SOD enzyme
activity in APAP hepatotoxicity.34,35 We suggest that this ﬁnding
occurred due to the decreased formation of free radicals followed
by TQ treatment. Moreover, decreased GSSG levels showed
decreased glutathione oxidation. The elevated enzyme activity of
SOD and the reduction of GSH-Px in the APAP group indirectly
showed an increase in the number of ROS in hepatic tissue. The
elevated SOD enzyme activity is one of the parts of the antioxidant
defense system. Oxidative stress at the ﬁrst level will be encoun-
tered by increased antioxidant enzyme activities. Interestingly,
statistically signiﬁcant decreases in SOD enzyme activity was seen
in the APAP þ TQ group when compared to the APAP group. The
exact mechanism of TQ on the enzyme activities is not yet known;
however, it can be speculated that TQmay affect the transcriptional
and/or translational pathways of these antioxidant enzymes.
Another explanation for this effect of TQmay be that it prevents the
induction of the enzymes (GSH-Px) by the inhibition of toxic
oxidative products. Mirochnitchenko et al. showed a remarkablyTable 3
The comparison of histopathological evaluation scores of rat liver tissue between the
groups.
Group I
(Control)
Group II
(TQ)
Group III
(APAP)
Group IV
(APAP þ TQ)
mean  SD 0.2  0.4 0.3  0.4 3  0.6a,b 1.5  0.8a,b,c
minemax 0e1 0e1 2e4 0e3
TQ: Thymoquinone, APAP: Acetaminophene.
a Signiﬁcantly different when compared with control group, (p  0.001).
b Signiﬁcantly different when compared with TQ group, (p  0.001).
c Signiﬁcantly different when compared with APAP group, (p  0.001).elevated resistance against APAP-induced hepatotoxicity in trans-
genic animals that have excessively high GSH-Px levels.36 We
suggest that TQ treatment may have a role in the regulation of
antioxidant mechanisms.
In conclusion, we have shown the therapeutic effect of TQ in
terms of the regulation of antioxidant activity in APAP-induced
hepatotoxicity. Our ﬁndings suggest that TQ may be an alterna-
tive therapeutic agent to NAC in APAP toxicity. There are re-
quirements for future studies.
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